1 Oct | 2024 Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT. Alakonya, H, Koustoulidou, S, Hopkins, SL, Veal, M, Ajenjo, J, Sneddon, D, Dias, G, Mosley, M, Baguña Torres, J , Amoroso, F, Anderson, A, Banham, AH, Cornelissen, B. J Nucl Med - 65 (10) : 1626-1632 (PMID: 39266290) (doi:10.2967/jnumed.124.267736)
28 Jul | 2022 Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration. Torres, JB , Roodselaar, J, Sealey, M, Ziehn, M, Bigaud, M, Kneuer, R, Leppert, D, Weckbecker, G, Cornelissen, B, Anthony, DC. Front Immunol - 13 : 814064 (PMID: 35967378) (doi:10.3389/fimmu.2022.814064)
1 Dec | 2020 Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer. Torres, JB , Mosley, M, Koustoulidou, S, Hopkins, S, Knapp, S, Chaikuad, A, Kondoh, M, Tachibana, K, Kersemans, V, Cornelissen, B. J Nucl Med - 61 (12) : 1756-1763 (PMID: 32414951) (doi:10.2967/jnumed.120.243113)
1 Oct | 2020 [18F]AZD2461, an Insight on Difference in PARP Binding Profiles for DNA Damage Response PET Imaging. Guibbal, F, Hopkins, SL, Pacelli, A, Isenegger, PG, Mosley, M, Torres, JB , Dias, GM, Mahaut, D, Hueting, R, Gouverneur, V, Cornelissen, B. Mol Imaging Biol - 22 (5) : 1226-1234 (PMID: 32342268) (doi:10.1007/s11307-020-01497-6)
1 Jul | 2020 Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling. Knight, JC, Torres, JB , Goldin, R, Mosley, M, Dias, GM, Bravo, LC, Kersemans, V, Allen, PD, Mukherjee, S, Smart, S, Cornelissen, B. J Nucl Med - 61 (7) : 1006-1013 (PMID: 31862800) (doi:10.2967/jnumed.119.234708)
1 May | 2020 Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy. O'Neill, E, Kersemans, V, Allen, PD, Terry, SYA, Torres, JB , Mosley, M, Smart, S, Lee, BQ, Falzone, N, Vallis, KA, Konijnenberg, MW, de Jong, M, Nonnekens, J, Cornelissen, B. J Nucl Med - 61 (5) : 743-750 (PMID: 31757844) (doi:10.2967/jnumed.119.232934)
1 Jul | 2019 Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance. Tacconi, EM, Badie, S, De Gregoriis, G, Reisländer, T, Lai, X, Porru, M, Folio, C, Moore, J, Kopp, A, Baguña Torres, J , Sneddon, D, Green, M, Dedic, S, Lee, JW, Batra, AS, Rueda, OM, Bruna, A, Leonetti, C, Caldas, C, Cornelissen, B, Brino, L, Ryan, A, Biroccio, A, Tarsounas, M. EMBO Mol Med - 11 (7) : e9982 (PMID: 31273933) (doi:10.15252/emmm.201809982)
1 Apr | 2018 Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody. Torres, JB , Knight, JC, Mosley, MJ, Kersemans, V, Koustoulidou, S, Allen, D, Kinchesh, P, Smart, S, Cornelissen, B. Mol Imaging Biol - 20 (2) : 292-299 (PMID: 28842811) (doi:10.1007/s11307-017-1112-8)
15 Nov | 2017 Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of 64Cu acetate and 64CuGTSM. Andreozzi, EM, Torres, JB , Sunassee, K, Dunn, J, Walker-Samuel, S, Szanda, I, Blower, PJ. Metallomics - 9 (11) : 1622-1633 (PMID: 29063080) (doi:10.1039/c7mt00227k)
31 Oct | 2017 Copper complexes with dissymmetrically substituted bis(thiosemicarbazone) ligands as a basis for PET radiopharmaceuticals: control of redox potential and lipophilicity. Brown, OC, Baguña Torres, J , Holt, KB, Blower, PJ, Went, MJ. Dalton Trans - 46 (42) : 14612-14630 (PMID: 28703233) (doi:10.1039/c7dt02008b)
22 Nov | 2016 Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines. Edmonds, S, Volpe, A, Shmeeda, H, Parente-Pereira, AC, Radia, R, Baguña-Torres, J , Szanda, I, Severin, GW, Livieratos, L, Blower, PJ, Maher, J, Fruhwirth, GO, Gabizon, A, T M de Rosales, R. ACS Nano - 10 (11) : 10294-10307 (PMID: 27781436) (doi:10.1021/acsnano.6b05935)
1 Jan | 2016 PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease. Torres, JB , Andreozzi, EM, Dunn, JT, Siddique, M, Szanda, I, Howlett, DR, Sunassee, K, Blower, PJ. J Nucl Med - 57 (1) : 109-114 (PMID: 26449834) (doi:10.2967/jnumed.115.162370)